ArticleThoracic cancer2022

Predictive value of post-treatment C-reactive protein-to-albumin ratio in locally advanced non-small cell lung cancer patients receiving durvalumab after chemoradiotherapy.

Taisuke Araki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.